Daniel O'Mahony

Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO.

Foster's Group Pty Ltd. produces and markets alcoholic and non-alcoholic beverages. It offers beers under the VB, Carlton Draught, Corona Extra, Crown Lager, Pure Blonde, Carlton Mid, and Carlton Dry brand names, as well as imports and licenses international brands, such as Asahi, Corona, and Stella Artois. The company was founded by William Foster and Ralph Foster in 1888 and is headquartered in Southbank, Australia.

PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.

Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland.

Cilag GmbH International conducts and coordinates international business in the pharmaceutical, chemical, consumer goods, medical products, and food products sectors. It also engages in the management of the corresponding research and development, particularly with reference to trading with products in these sectors. The company was founded in 1984 and is headquartered in Zug, Switzerland.

Vivasure Medical Ltd. manufactures medical devices to enable deployment of vascular implants. It offers an absorbable implant and delivery system for use in a range of medical applications, primarily in minimally invasive and percutaneous procedures, such as percutaneous closure of arteriotomies. The company was founded by Gerard Brett and Christopher Martin on August 27, 2008 and is headquartered in Galway, Ireland.

Global Center For Medical Innovation, Inc. provides medical devices. It provides medical device commercialization, innovation, prototyping, machine shop, cGMP manufacturing, preclinical testing, clinical trial, inovator education, regulatory assurance, quality assurance, 3D Printing-ProJet 6000, rapid prototyping, cleanroom. The company is headquartered in Atlanta, GA.

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.

Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom.

Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland.

PrecisionBiotics Group Ltd. operates as a healthcare company. It focuses on isolation, characterization, clinical evaluation, and formulation of unique bacterial strain and actives for inflammatory and infectious conditions. The company was founded by Barry Kiely in 1999 and is headquartered In Cork, Ireland.

Walter Rau Neusser Oel und Fett AG produces and distributes functional fats and oils from vegetable raw materials. Its solutions are product development, market investigation, customer solution center, toll processing, health, product solutions, and service solutions. The company was founded in 1887 and is headquartered in Neuss, Germany.

Part of Bunge Global SA, Bunge Loders Croklaan BV is a leading producer and supplier of plant-based specialty oils and fats for the food manufacturing and food service industry. The company is based in Holland, the Netherlands. Bunge Loders Croklaan operates as part of the B2B edible oils business of Bunge Limited (NYSE:BG). Its products are used in a wide range of applications, from bakery and confectionery to culinary and infant nutrition. With in-depth knowledge of ingredients, applications, and processes, the Bunge Loders Croklaan team closely cooperates with customers to develop tailored solutions and create innovative products to meet their business goals and differentiate them in the marketplace.

Foodbank New South Wales Ltd. operates as a non-profit organization. It collects surplus, salvaged, and donated food and grocery products from food manufacturers, distributor retailers, and distributes it via charitable welfare agencies. The company is headquartered in Plumpton, Australia.

PricewaterhouseCoopers provides audit, assurance and crisis management services. The company was founded in 1971 and is headquartered in Muscat, Oman.

Jurys Doyle Hotel Group Plc owns and operates hotels in Ireland, the UK, and the US. Its brands include Jurys Hotels, Jurys Inns, Westbury, Berkeley Court, and Towers. The company was founded in 1881 by William Jury and is headquartered in Dublin, Ireland.

Procter & Gamble Technical Centers Ltd. conducts research for health and beauty care products. It also involved in the development of its hair care products, skin care items, cosmetics, oral care products, fragrances, deodorants, and respiratory medicines. The company is headquartered in Egham, UK.

Part of ITV Plc, Forte Hotels Group is a British company that operates the Swans Nest Hotel. The company is based in London, UK.

Ion Equity Ltd. (Ion Equity) is a private equity firm founded in 2000 by Neil O'Leary, Joe Devine, and Ulric Kenny. The firm is headquartered in Dublin, Ireland with an additional office in London, United Kingdom.

Nualight Ltd. designs and manufactures LED products. It offers Alto, Porto, Largo, Centro, Titan, Blaze, Zest, Toro, Viga and Arc series. The firm’s products include LED pendants, ceiling-tiles, low bay/parking, refrigeration lighting and spotlights. Nualight was founded by John Bouchier, Liam Kelly and Paul O'Shaughnessy in May, 2004 and is headquartered in Cork, Ireland.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.

Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.